Evervac: phase I/II study of immunogenicity and safety of a new adjuvant-free TBE vaccine cultivated in Vero cell culture
Vorovitch, Mikhail F., Grishina, Karina G., Volok, Viktor P., Chernokhaeva, Liubov L., Grishin, Konstantin V., Karganova, Galina G., Ishmukhametov, Aidar A.Journal:
Human Vaccines & Immunotherapeutics
DOI:
10.1080/21645515.2020.1757990
Date:
May, 2020
Fichier:
PDF, 1.83 MB
2020
File converter
Plus de résultats de recherche
More benefits 
